Literature DB >> 19343764

Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.

Yusuf Tanrikulu1, Ewgenij Proschak, Tim Werner, Tim Geppert, Nickolay Todoroff, Alexander Klenner, Tim Kottke, Kerstin Sander, Erich Schneider, Roland Seifert, Holger Stark, Timothy Clark, Gisbert Schneider.   

Abstract

A computer-assisted method for the generation of pseudoreceptor models is presented together with two practical applications. From a three-dimensional alignment of known histamine H(4) receptor ligands, a pseudoreceptor model of the putative ligand binding site was constructed and used for virtual screening of a large collection of commercially available compounds. Two bioactive chemotypes were retrieved, demonstrating the general applicability of the approach. The pseudoreceptor model was also used to find the putative ligand binding pocket within the transmembrane receptor domain. For each frame of a molecular dynamics simulation of a homology-based H(4) receptor model, we automatically extracted potential ligand binding pockets and used their compatibility with the pseudoreceptor as a selection criterion. The best-matching pocket fits perfectly with existing mutation data and previously published hypotheses suggesting Glu182(5.46) as the preferred binding partner of a positively charged moiety of H(4) receptor ligands. This new pseudoreceptor approach has demonstrated its suitability for both structure-based prioritization of protein receptor models, and ligand-based virtual screening with the aim to perform scaffold hopping.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343764     DOI: 10.1002/cmdc.200800443

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  7 in total

Review 1.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

Review 2.  Understanding functional residues of the cannabinoid CB1.

Authors:  Joong-Youn Shim
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

3.  Lead identification and optimization of diaminopyrimidines as histamine H4 receptor ligands.

Authors:  K Sander; T Kottke; E Proschak; Y Tanrikulu; E H Schneider; R Seifert; G Schneider; H Stark
Journal:  Inflamm Res       Date:  2010-03       Impact factor: 4.575

4.  Spherical harmonics coefficients for ligand-based virtual screening of cyclooxygenase inhibitors.

Authors:  Quan Wang; Kerstin Birod; Carlo Angioni; Sabine Grösch; Tim Geppert; Petra Schneider; Matthias Rupp; Gisbert Schneider
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

5.  DOGS: reaction-driven de novo design of bioactive compounds.

Authors:  Markus Hartenfeller; Heiko Zettl; Miriam Walter; Matthias Rupp; Felix Reisen; Ewgenij Proschak; Sascha Weggen; Holger Stark; Gisbert Schneider
Journal:  PLoS Comput Biol       Date:  2012-02-16       Impact factor: 4.475

6.  In Silico Adoption of an Orphan Nuclear Receptor NR4A1.

Authors:  Harald Lanig; Felix Reisen; David Whitley; Gisbert Schneider; Lee Banting; Timothy Clark
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

7.  Sequential application of ligand and structure based modeling approaches to index chemicals for their hH4R antagonism.

Authors:  Matteo Pappalardo; Nir Shachaf; Livia Basile; Danilo Milardi; Mouhammed Zeidan; Jamal Raiyn; Salvatore Guccione; Anwar Rayan
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.